The recent Rio Olympics 2016 saw widespread doping violations which were reported as the worst in the Game’s history. Drug screening has played a key role in determining drug use in this event and many Rio competitors were banned for returning positive drug tests. Doping scandal was a serious concern in the Olympics as well as other sports settings such as NFL and Major League Baseball. Athletes have been taking performance-enhancing drugs since the first Olympic Games in ancient Greece. Reports highlight that the athletes take drugs such as anabolic steroids, erythropoietin and stimulants like amphetamines and cocaine to improve performance.
Drug-testing plays an integral role not only in sports, but also in ongoing evaluation and treatment. It is done in schools, hospitals, and places of employment, for college and post accident drug testing. Drug screening is used to detect illegal as well as some prescribed drugs in the blood, urine, and other biological samples.
Laboratory-based screening and onsite screening tests are available. Urine Drug Tests are the most common test type used in drug of abuse testing. FDA-approved urine drug test cups are now available that facilitate on-site testing. These test cups come with custom configurations and are designed to provide accurate and quick test results in just five minutes.
According to the latest market report published by Credence Research, Inc, the drug abuse testing/screening market that was valued at USD 3,303.4 Mn in 2015 is expected to reach USD 4,555.9 Mn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022. As per the report, the key factors that drive the growth of drug of abuse testing market are:
- Globally rising consumption of illicit drugs
- Adoption of drug of abuse (DOA) testing at organizational level
- Increased production of illicit drugs and their trade
- Increasing death rates/road accidents due to drug abuse
The key players in this market are Roche Holding Limited, Quest Diagnostics, Laboratory Corporation of America Holdings, Alere, Inc., Abbott Laboratories, Randox laboratories, Psychemedics Corporation, Bio-Rad Laboratories, Sonic Healthcare and Thermo Fisher Scientific.
Another drug screening market report from Persistence Market Research notes that factors such as accuracy issues related to breathalyzers, ban on alcohol consumption in various countries, and the fact that drug testing is considered as a violation of privacy rights in some countries, act as major restraints for the growth of the global market.
Based on geography, North America dominates the global market for drug screening due to increase in the number of drug and alcohol abuse cases and enactment of stringent laws in the region. With China and India being the fastest-growing markets in Asia Pacific, Asia is expected to exhibit a high growth rate in the next five years in the global drug screening market.